LENZ Therapeutics(LENZ)
SOLANA BEACH, CABiotechnology
Focus: LENZ Therapeutics is a public biotech company focused exclusively on ophthalmology treatments, particularly presbyopia solutions. The company is pre-revenue with an early-stage commercial footprint.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
10
Should You Work at LENZ Therapeutics?
AI assessmentHigh-risk, high-reward opportunity best suited for early-stage biotech specialists willing to bet on ophthalmology focus and pipeline catalysts against existential cash concerns.
Why Work Here
- Focused therapeutic area (ophthalmology) enables deep domain expertise and potential to become a recognized specialist
- Recently launched VIZZ (aceclidine) product provides early commercial momentum and revenue inflection opportunity
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Key Products
Growing
Growth17.7yr
First and only marketed product; recently launched with 19-year exclusivity window providing long revenue runway if successfully adopted.
Help build intelligence for LENZ Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.